Trademark: CTX211
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
Proof of use for CTX211
We do not have any records of a proof of use for CTX211 at this moment.
Possible trademark infringements of CTX211
Basic Information about CTX211
- Serial Number
- 98347437
- Filing Date
- 08 Jan 2024
- Mark Drawing Code
- 4
Classifications
Declare the trademark use of CTX211 on the blockchain with WikiTrademarks.io.
- First use of CTX211 anywhere
- No first use declared yet.
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 005
- US Codes
- 005; 006; 018; 044; 046; 051; 052
- First use of CTX211 anywhere
- No first use declared yet.
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 042
- US Codes
- 100; 101
Who owns CTX211?
1. CRISPR Therapeutics AG ZUG V8
Correspondent
- Tiffany D. Gehrke Marshall, Gerstein & Borun LLP
- 233 South Wacker Drive
- Suite 6300
- Chicago, IL 60606
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io